Synthesis and characterization of the biological activity of the cisplatin analogs, cis-PtCl2(dexrazoxane) and cis-PtCl2(levrazoxane), of the topoisomerase II inhibitors dexrazoxane (ICRF-187) and levrazoxane (ICRF-186)

This publication has 16 references indexed in Scilit:

• Topoisomerase II Poisoning by ICRF-193
  Journal of Biological Chemistry, 2001
• Reactions of N,N′-dicarboxamido-N,N′-dicarboxymethyl-1,2-diaminoethane (EDTA–diamide) with hydrated ruthenium(III) chloride and potassium tetrachloroplatinate(II). Crystal and molecular structures of the pentadentate EDTA–H complex NH4[Ru(EDTA–H)Cl] · 2H2O and the EDTA–imide complex PtCl2[2(HOOCCH2)NCH2CH2NCH2CONHCOCH2] · 2H2O
  Polyhedron, 1998
• The preparation and crystal and molecular structure of the complex cis-PtCl2(razoxane)
  Inorganica Chimica Acta, 1998
• [20] Processing of X-ray diffraction data collected in oscillation mode
  Published by Elsevier ,1997
• Improved understanding in platinium antitumour chemistry
  Chemical Communications, 1996
• An empirical correction for absorption anisotropy
  Acta Crystallographica Section A Foundations of Crystallography, 1995
• An HPLC and spectrophotometric study of the hydrolysis of ICRF-187 (dexrazoxane, (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane) and its one-ring opened intermediates
  International Journal of Pharmaceutics, 1994
• The one-ring open hydrolysis product intermediates of the cardioprotective agent ICRF-187 (dexrazoxane) displace iron from iron-anthracycline complexes
  Inflammation Research, 1993
• When good enzymes go bad: Conversion of topoisomerase II to a cellular toxin by antineoplastic drugs
  Chemical Research in Toxicology, 1993
• Antitumour Activity in a Series of bisDiketopiperazines
  Nature, 1969